Transcription factors, normal myeloid development, and leukemia

Blood

Volumn 90, Issue 2, 1997, Pages 489-519

  Tenen, Daniel G ^a   Hromas, Robert ^b   Licht, Jonathan D ^b   Zhang, Dong Er ^b  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; CELL DIFFERENTIATION; GENE ACTIVATION; GENE CONTROL; GENE TARGETING; GENE THERAPY; LEUKEMIA; LEUKEMOGENESIS; ONCOGENE C MYB; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; TATA BOX; TRANSGENE;

EID: 0030854907     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.2.489     Document Type: Review

References (456)

1. Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987, 1987
2. Blau HM, Baltimore D: Differentiation requires continuous regulation. J Cell Biol 112:781, 1991
3. Shivdasani RA, Orkin SH: The transcriptional control of hematopoiesis. Blood 87:4025, 1996
4. Orkin SH: Transcription factors and hematopoietic development. J Biol Chem 270:4955, 1995
5. Pevny L, Simon MC, Robenson E, Klein WH, Tsai SF, D'Agati V, Orkin SH, Costantini F: Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257, 1991
6. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH: The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78:45, 1994
7. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:432, 1995
8. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, Sharpe A: The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143, 1994
9. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:901, 1994
10. Lubbert M, Herrmann F, Koeffler HP: Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. Blood 77:909, 1991
11. Nichols J, Nimer SD: Transcription factors, translocations, and leukemia. Blood 80:2953, 1992
12. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143, 1994
13. 12a. Wolff L: Contribution of oncogenes and tumor suppressor genes to myeloid leukemia. Biochim Biophys Acta 1332:F67, 1997
14. Darnell JE, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415, 1994
15. Moreau-Gachelin F: Spi-1/PU.1: An oncogene of the ets family. Biochim Biophys Acta 1198:149, 1994
16. Kehrl JH: Hematopoietic lineage commitment: Role of transcription factors. Stem Cells 13:223, 1995
17. Shapiro LH, Look AT: Transcriptional regulation in myeloid cell differentation. Curr Opin Hematol 2:3, 1995
18. Nucifora G, Rowley JD: AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1, 1995
19. Hagman J, Grosschedl R: Regulation of gene expression at early stages of B-cell differentiation. Curr Opin Immunol 6:222, 1994
20. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, LoCoco F, Pelicci PG: Acute promyelocytic leukemia - From genetics to treatment. Blood 83:10, 1994
21. Metcalf D: Hematopoietic regulators - Redundancy or subtlety. Blood 82:3515, 1993
22. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM: Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332:376, 1988
23. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM: Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823, 1993
24. Just U, Friel J, Heberlein C, Tamura T, Baccarini M, Tessmer U, Klinger K, Ostertag W: Upregulation of lineage specific receptors and ligands in multipotential prognitor cells is part of an endogenous program of differentiation. Growth Factors 9:291, 1993
25. Pedersen-Bjergaard J, Rowley JD: The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780, 1994
26. Nguyen HQ, Hoffman-Liebermann B, Liebermann DA: The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell 72:197, 1993
27. Scott EW, Simon MC, Anastai J, Singh H: The transcription factor PU.1 is required for the development of multiple hematopoietic lineages. Science 265:1573, 1994
28. Torbett BE, McKercher SC, Anderson KL, Vestal DJ, Henkel G, Maki RA: The disruption of the gene for the transcription factor PU.1 leads to multiple hematopoietic defects. Blood 86:251a, 1995 (abstr, suppl 1)
29. Zhang D-E, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG: Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc Natl Acad Sci USA 94:569, 1997
30. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott WJ Jr, Potter SS: A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677, 1991
31. Hromas R, Collins SJ, Hickstein D, Raskind W, Deaven LL, O'Hara P, Hagen FS, Kaushansky K: A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J Biol Chem 266:14183, 1991
32. Giampaolo A, Sterpetti P, Bulgarini D, Samoggia P, Pelosi E, Valtieri M, Peschle C: Key functional role and lineage-specific expression of selected HOXB genes in purified hematopoietic progenitor differentiation. Blood 84:3637, 1994
33. Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C, Lawrence HJ, Humphries RK: Differential expression of homeobox genes in functionally distinct CD34(+) subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 91:12223, 1994
34. Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C: Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Exp Hematol 23:1160, 1995
35. Coppola JA, Cole MD: Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 320:760, 1986
36. Adams JM, Cory S: Transgenic models of tumor development. Science 254:1161, 1991
37. Kreider BL, Benezra R, Rovera G, Kadesch T: Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 255:1700, 1992
38. Moreau-Gachelin F, Tavitian A, Tambourin P: Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331:277, 1988
39. Paul R, Schuetze S, Kozak SL, Kozak CA, Kabat D: The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J Virol 65:464, 1991
40. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88:10431, 1991
41. Chen SJ, Zelent A, Tong JH, Yu HQ, Wang ZY, Derre J, Berger R, Waxman S, Chen Z: Rearrangements of the retinoic acid receptor-alpha and promyelocytic leukemia zinc finger genes resulting from t(11-17)(q23-q21) in a patient with acute promyelocytic leukemia. J Clin Invest 91:2260, 1993
42. Holt JT, Redner RL, Nienhuis AW: An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 8:963, 1988
43. Gewirtz AM, Calabretta B: A c-myb antisense oligodeoxy-nucleotide inhibits normal human hematopoiesis in vitro. Science 242:1303, 1988
44. Bavisotto L, Kaushansky K, Lin N, Hromas R: Antisense oligonucleotides from the stage-specific myeloid zinc finger gene MZF-1 inhibit granulopoiesis in vitro. J Exp Med 174:1097, 1991
45. Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG: Inhibition of hematopoiesis by competitive binding of the transcription factor PU.1. Proc Natl Acad Sci USA 91:7932, 1994
46. Tsai S, Collins SJ: A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90:7153, 1993
47. Shin MK, Koshland ME: Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element. Genes Dev 7:2006, 1993
48. Kominato Y, Galson DL, Waterman WR, Webb AC, Auron PE: Monocyte-specific expression of the human prointerleukin 1β gene (IL1β) is dependent upon promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.1. Mol Cell Biol 15:58, 1995
49. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH: An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371:221, 1994
50. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR: AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321, 1996
51. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA: Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoesis. Proc Natl Acad Sci USA 93:3444, 1996
52. Maniatis T, Goodbourn S, Fischer JA: Regulation of inducible and tissue-specific gene expression. Science 236:1237, 1987
53. Zhang D-E, Fujioka KI, Hetherington CJ, Shapiro LH, Chen HM, Look AT, Tenen DG: Identification of a region which directs monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol 14:8085, 1994
54. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG: PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88:1234, 1996
55. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang D-E, Tenen DG: PU.1 (Spi-1) and C/EBPα regulate the expression of the granulocyte-macrophage colony-stimuating factor receptor a gene. Mol Cell Biol 15:5830, 1995
56. Chen HM, Ray-Gallet D, Zhang P, Hetherington CJ, Gonzalez DA, Zhang D-E, Moreau-Gachelin F, Tenen DG: PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 11:1549, 1995
57. Kistler B, Pfisterer P, Wirth T: Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors. Oncogene 11:1095, 1995
58. Hagemeier C, Bannister AJ, Cook A, Kouzarides T: The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA 90:1580, 1993
59. Eichbaum QG, Iyer R, Raveh DP, Mathieu C, Ezekowitz AB: Restriction of interferon gamma responsiveness and basal expression of the myeloid human FcgammaR1b gene is mediated by a functional PU.1 site and a transcription initiator consensus. J Exp Med 179:1985, 1994
60. Emili A, Greenblatt J, Ingles CJ: Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol 14:1582, 1994
61. Zwilling S, Annweiler A, Wirth T: The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. Nucleic Acids Res 22:1655, 1994
62. Nerlov C, Ziff EB: CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability cooperate to activate transcription in both yeast and mammalian cells. EMBO J 14:4318, 1995
63. Roberts WM, Shapiro LH, Ashmun RA, Look AT: Transcription of the human colony-stimulating factor-1 receptor gene is regulated by separate tissue-specific promoters. Blood 79:586, 1992
64. Fleming JC, Pahl HL, Gonzalez DA, Smith TF, Tenen DG: Structural analysis of the CD11b gene and phylogenetic analysis of the alpha-integrin gene family demonstrate remarkable conservation of genomic organization and suggest early diversification during evolution. J Immunol 150:480, 1993
65. Seto Y, Fukunaga R, Nagata S: Chromosomal gene organization of the human granulocyte colony-stimulating factor receptor. J Immunol 148:259, 1992
66. Chen HM, Pahl HL, Scheibe RJ, Zhang D-E, Tenen DG: The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity. J Biol Chem 268:8230, 1993
67. Zhang D-E, Hetherington CJ, Tan S, Dziennis SE, Gonzalez DA, Chen HM, Tenen DG: Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem 269:11425, 1994
68. Zhang D-E, Hetherington CJ, Gonzalez DA, Chen HM, Tenen DG: Regulation of CD14 expression during monocytic differentiation induced with 1alpha,25-Dihydroxyvitamin D3. J Immunol 153:3276, 1994
69. Saffer JD, Jackson SP, Annarella MB: Developmental expression of Sp1 in the mouse. Mol Cell Biol 11:2189, 1991
70. Darrow AL, Rickles RJ, Pecorino LT, Strickland S: Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation. Mol Cell Biol 10:5883, 1990
71. Kim SJ, Onwuta US, Lee YI, Li R, Botchan MR, Robbins PD: The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol 12:2455, 1992
72. Udvadia AJ, Rogers KT, Higgins PDR, Murata Y, Martin KH, Humphrey PA, Horowitz JM: Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc Natl Acad Sci USA 90:3265, 1993
73. Chen LI, Nishinaka T, Kwan K, Kitabayashi I, Yokoyama K, Fu YHF, Grunwald S, Chiu R: The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol Cell Biol 14:4380, 1994
74. Hagen G, Muller S, Beato M, Suske G: Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 13:3843, 1994
75. Zhang R, Tsai FY, Orkin SH: Hematopoietic development of vav(-/-) mouse embryonic stem cells. Proc Natl Acad Sci USA 91:12755, 1994
76. Fischer KD, Haese A, Nowock J: Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. J Biol Chem 268:23915, 1993
77. Pahl HL, Rosmarin AG, Tenen DG: Characterization of the myeloid-specific CD11b promoter. Blood 79:865, 1992
78. Martin F, Prandini MH, Thevenon D, Marguerie G, Uzan G: The transcription factor GATA-1 regulates the promoter activity of the platelet glycoprotein-IIb gene. J Biol Chem 268:21606, 1993
79. Lee ME, Temizer DH, Clifford JA, Quertermous T: Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem 266:16188, 1991
80. Zon LI, Yamaguchi Y, Yee K, Albee EA, Kimura A, Bennett JC, Orkin SH, Ackerman SJ: Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: Potential role in gene transcription. Blood 81:3234, 1993
81. Visvader JE, Elefanty AG, Strasser A, Adams JM: GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J 11:4557, 1992
82. Kulessa H, Frampton J, Graf T: GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 9:1250, 1995
83. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM: Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 90:2380, 1993
84. Tenen DG: unpublished data.
85. Ahne B, Stratling WH: Characterization of a myeloid-specific enhancer of the chicken lysozyme gene - Major role for an Ets transcription factor-binding site. J Biol Chem 269:17794, 1994
86. Bonifer C, Vidai M, Grosveld F, Sippel AE: Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J 9:2843, 1990
87. Morishita K, Tsuchiya M, Asano S, Kaziro Y, Nagata S: Chromosomal gene structure of human myeloperoxidase and regulation of its expression by granulocyte colony-stimulating factor. J Biol Chem 262:15208, 1987
88. Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S, Friedman AD: PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2beta/CBFbeta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 14:5558, 1994
89. Oelgeschlager M, Nuchprayoon I, Luscher B, Friedman AD: C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol 16:4717, 1996
90. Sturrock A, Franklin KF, Hoidal JR: Human proteinase-3 expression is regulated by PU.1 in conjunction with a cytidine-rich element. J Biol Chem 271:32392, 1996
91. Grisolano JL, Sclar GM, Ley TJ: Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci USA 91:8989, 1994
92. Shapiro LH, Ashmun RA, Roberts WM, Look AT: Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells. J Biol Chem 266:11999, 1991
93. Avalos BR: Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88:761, 1996
94. Rosmarin AG, Weil SC, Rosner GL, Griffin JD, Arnaout MA, Tenen DG: Differential expression of CD11b/CD18 (Mol) and myeloperoxidase genes during myeloid differentiation. Blood 73:131, 1989
95. Hickstein DD, Back AL, Collins SJ: Regulation of expression of the CD11b and CD18 subunits of the neutrophil adherence receptor during human myeloid differentiation. J Biol Chem 264:21812, 1989
96. Chen HM, Zhang P, Voso MT, Hohaus S, Gonzalez DA, Glass CK, Zhang D-E, Tenen DG: Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85:2918, 1995
97. Farokhzad OO, Shelley CS, Arnaout MA: Induction of the CD11b gene during activation of the monocytic cell line U937 requires a novel nuclear factor MS-2. J Immunol 157:5597, 1996
98. Wu H, Moulton K, Horvai A, Parik S, Glass CK: Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol Cell Biol 14:2129, 1994
99. Tsukada J, Saito K, Waterman WR, Webb AC, Auron PE: Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1β gene. Mol Cell Biol 14:7285, 1994
100. Tsukada J, Waterman WR, Koyama Y, Webb AC, Auron PE: A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene. Mol Cell Biol 16:2183, 1996
101. Kozak M: An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:8125, 1987
102. Hehlgans T, Strominger JL: Activation of transcription by binding of NF-E1 (YY1) to a newly identified element in the first exon of the human DR alpha gene. J Immunol 154:5181, 1995
103. Grosveld F, van Assendelft GB, Greaves DR, Kollias G: Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 51:975, 1987
104. Skalnik DG, Dorfman D, Perkins AS, Jenkins NA, Copeland NG, Orkin SH: Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc Natl Acad Sci USA 88:8505, 1991
105. Greer P, Maltby V, Rossant J, Bernstein A, Pawson T: Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice. Mol Cell Biol 10:2521, 1990
106. Bonifer C, Yannoutsos N, Kruger G, Grosveld F, Sippel AE: Dissection of the locus control function located on the chicken lysozyme gene domain in transgenic mice. Nucleic Acids Res 22:4202, 1994
107. Miyazaki T, Suzuki G, Yamamura K-I: The role of macrophages in antigen presentation and T cell tolerance. Int Immunol 5:1023, 1993
108. Jin DI, Jameson SB, Reddy MA, Schenkman D, Ostrowski MC: Alterations in differentiation and behavior of monocytic phagocytes in transgenic mice that express dominant suppressors of ras signaling. Mol Cell Biol 15:693, 1995
109. Lagasse E, Weissman IL: bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 179:1047, 1994
110. Brown D, Kogan S, Lagasse E, Weissman IL, Alcalay M, Pelicci PG, Atwater S, Bishop JM: A PMLRARa transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 94:2551, 1997
111. Clarke S, Greaves DR, Chung LP, Tree P, Gordon S: The human lysozyme promoter directs reporter gene expression to activated myelomonocytic cells in transgenic mice. Proc Natl Acad Sci USA 93:1434, 1996
112. Dziennis S, Tenen DG: The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood 85:1983, 1995
113. Back A, East K, Hickstein D: Leukocyte integrin CD11b promoter directs expression in lymphocytes and granulocytes in transgenic mice. Blood 85:1017, 1995
114. Early E, Moore MAS, Kakizuka A, Nason-Burchenal K, Martin P, Evans RM, Dmitrovsky E: Transgenic expression of PML/RARa impairs myelopoiesis. Proc Natl Acad Sci USA 93:7900, 1996
115. De Sepulveda P, Salaun P, Maas N, Andre C, Panthier JJ: SARs do not impair position-dependent expression of a kit/lacZ transgene. Biochem Biophys Res Commun 211:735, 1995
116. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ: Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARa under control of cathepsin G regulatory sequences. Blood 89:376, 1997
117. Pahl HL, Scheibe RJ, Zhang D-E, Chen HM, Galson DL, Maki RA, Tenen DG: The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem 268:5014, 1993
118. Zhang D-E, Hetherington CJ, Chen HM, Tenen DG: The macrophage transcription factor PU.1 directs tissue specific expression of the macrophage colony stimulating factor receptor. Mol Cell Biol 14:373, 1994
119. Ray-Gallet D, Mao C, Tavitian A, Moreau-Gachelin F: DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene 11:303, 1995
120. Heydemann A, Juang G, Hennessy K, Parmacek MS, Simon MC: The myeloid cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol Cell Biol 16:1676, 1996
121. Horvai A, Palinski W, Wu H, Moulton KS, Kalla K, Glass CK: Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci USA 92:5391, 1995
122. Krall WJ, Challita PM, Perlmutter LS, Skelton DC, Kohn DB: Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood 83:2737, 1994
123. Bauer TR, Osborne WRA, Kwok WW, Hickstein DD: Expression from leukocyte integrin promoters in retroviral vectors. Hum Gene Ther 5:709, 1994
124. Malik P, Krall WJ, Yu XJ, Zhou C, Kohn DB: Retroviral-mediated gene expression in human myelomonocytic cells: A comparison of hematopoietic cell promoters to viral promoters. Blood 86:2993, 1995
125. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA: The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113, 1990
126. Schuetze S, Stenberg PE, Kabat D: The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol Cell Biol 13:5670, 1993
127. Moreau-Gachelin F, Wendling F, Molina T, Denis N, Titeux M, Grimber G, Briand P, Vainchenker W, Tavitian A: Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol 16:2453, 1996
128. Delgado MD, Hallier M, Meneceur P, Tavitian A, Moreau-Gachelin F: Inhibition of friend cells proliferation by spi-1 antisense oligodeoxynucleotides. Oncogene 9:1723, 1994
129. Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA, Gunther CV, Nye JA, Graves BJ: The ETS-domain: A new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev 4:1451, 1990
130. Wasylyk B, Hahn SL, Giovane A: The Ets family of transcription factors. Eur J Biochem 211:7, 1993
131. Ray D, Bosselut R, Ghysdael J, Mattei MG, Tavitian A, Moreau-Gachelin F: Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol 12:4297, 1992
132. Klemsz MJ, Maki RA: Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol Cell Biol 16:390, 1996
133. Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC: Mechanism of active transcriptional repression by the retino-blastoma protein. Nature 375:812, 1995
134. Kodandapani R, Pio F, Ni CZ, Piccialli G, Klemsz M, McKercher S, Maki RA, Ely KR: A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex. Nature 380:456, 1996
135. Cheng T, Shen H, Giokas D, Gere J, Tenen DG, Scadden DT: Temporal Mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc Natl Acad Sci USA 93:13158, 1996
136. Hromas R, Orazi A, Neiman RS, Maki R, Vanbeveran C, Moore J, Klemsz M: Hematopoietic lineage-restricted and stage-restricted expression of the ETS oncogene family member PU.1. Blood 82:2998, 1993
137. Schuetze S, Paul R, Gliniak BC, Kabat D: Role of the PU.1 transcription factor in controlling differentiation of Friend erythro-leukemia cells. Mol Cell Biol 12:2967, 1992
138. Galson DL, Hensold JO, Bishop TR, Schalling M, D'Andrea AD, Jones C, Auron PE, Housman DE: Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol Cell Biol 13:2929, 1993
139. Chen HM, Zhang P, Radomska HS, Hetherington CJ, Zhang D-E, Tenen DG: Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. J Biol Chem 271:15743, 1996
140. Oka T, Rairkar A, Chen JH: Structural and functional analysis of the regulatory sequences of the ets-1 gene. Oncogene 6:2077, 1991
141. Hensold JO, Stratton CA, Barth D, Galson DL: Expression of the transcription factor, Spi-1 (PU.1), in differentiating murine erythroleukemia cells is regulated post-transcriptionally - Evidence for differential stability of transcription factor mrnas following inducer exposure. J Biol Chem 271:3385, 1996
142. Wasylyk C, Kerckaert JP, Wasylyk B: A novel modulator domain of Ets transcription factors. Genes Dev 6:965, 1992
143. Nagulapalli S, Pongubala JM, Atchison ML: Multiple proteins physically interact with PU.1. J Immunol 155:4330, 1995
144. Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML: PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity. Mol Cell Biol 12:368, 1992
145. Pongubala JM, Van Beveren C, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML: Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259:1622, 1993
146. Eisenbeis CF, Singh H, Storb U: PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda-2-4 enhancer. Mol Cell Biol 13:6452, 1993
147. Eisenbeis CF, Singh H, Storb U: Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 9:1377, 1995
148. Wang CY, Petryniak B, Thompson CB, Kaelin WG, Leiden JM: Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260:1330, 1993
149. Chen PL, Scully P, Shew JY, Wang JY, Lee WH: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193, 1989
150. Furukawa Y, DeCaprio JA, Freedman A, Kanakura Y, Nakamura M, Ernst TJ, Livingston DM, Griffin JD: Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc Natl Acad Sci USA 87:2770, 1990
151. John S, Reeves RB, Lin JX, Child R, Leiden JM, Thompson CB, Leonard WJ: Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: Potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol Cell Biol 15:1786, 1995
152. Bassuk AG, Leiden JM: A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 3:223, 1995
153. Gauthier JM, Bourachot B, Doucas V, Yaniv M, Moreau-Gachelin F: Functional interference between the Spi-1/PU.1 onco-protein and steroid hormone or vitamin receptors. EMBO J 12:5089, 1993
154. Marais R, Wynne J, Treisman R: The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381, 1993
155. Rao VN, Reddy ESP: Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase. Cancer Res 53:3449, 1993
156. Rabault B, Ghysdael J: Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. J Biol Chem 269:28143, 1994
157. Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA, Ostrowski MC: Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol 16:538, 1996
158. Mao C, Ray-Gallet D, Tavitian A, Moreau-Gachelin F: Differential phosphorylations of Spi-B and Spi-1 transcription factors. Oncogene 12:863, 1996
159. Lodie TA, Savedra R, Golenbaock DT, Van Beveren CP, Maki RA, Fenton MJ: Stimulation of macrophages by LPS alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J Immunol 158:1848, 1997
160. Celada A, Borras FE, Soler C, Lloberas J, Klemsz M, Van Beveren C, McKercher SC, Maki RA: The transcription factor PU.1 is involved in macrophage proliferation. J Exp Med 184:61, 1996
161. Ford AM, Bennett CA, Healy LE, Towatari M, Greaves MF, Enver T: Regulation of the myeloperoxidase enhancer binding proteins PU.1, CEBPα, β, and δ during granulocytic-lineage specification. Proc Natl Acad Sci USA 93:10838, 1996
162. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, Maki RA: Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15:5647, 1996
163. Olson MC, Scott EW, Hack AA, Su GH, Tenen DG, Singh H, Simon MC: PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3:703, 1995
164. Henkel GW, McKercher SR, Yamamoto H, Anderson KL, Oshima RG, Maki RA: PU.1 but not Ets-2 is essential for macrophage development from ES cells. Blood 88:2917, 1996
165. Reddy MA, Yang BS, Yue X, Barnett CJK, Ross IL, Sweet MJ, Hume DA, Ostrowski MC: Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes. J Exp Med 180:2309, 1994
166. Hallier M, Tavitian A, Moreau-Gachelin F: The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54(nrb). J Biol Chem 271:11177, 1996
167. Moulton KS, Semple K, Wu H, Glass CK: Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif. Mol Cell Biol 14:4408, 1994
168. Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS, Seth A: The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA 90:7588, 1993
169. Klemsz MJ, Maki RA, Papayannopoulou T, Moore J, Hromas R: Characterization of the ets oncogene family member, fli-1. J Biol Chem 268:5769, 1993
170. Ross IL, Dunn TL, Yue X, Roy S, Barnett CJK, Hume DA: Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes. Oncogene 9:121, 1994
171. 2 leukocyte integrin) transcription. J Biol Chem 270:23627, 1995
172. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor beta to a novel ETS-like gene, Tel, in chronic myelomonocytic leukemia with t(5:12) chromosomal translocation. Cell 77:307, 1994
173. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Brayward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG: Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917, 1995
174. Golub TR, Mclean T, Stegmaier K, Carroll M, Tomasson M, Gilliland DG: The TEL gene and human leukemia. Bba-Rev Cancer 1288:M7, 1996
175. Johnson PF, Landschulz WH, Graves BJ, McKnight SL: Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev 1:133, 1987
176. Landschulz WH, Johnson PF, Adashi EY, Graves BJ, McKnight SL: Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 2:786, 1988
177. Landschulz WH, Johnson PF, McKnight SL: The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science 243:1681, 1989
178. Johnson PF, McKnight SL: Eukaryotic transcriptional regulatory proteins.
179. Vallejo M, Ron D, Miller CP, Habener JF: C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci USA 90:4679, 1993
180. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538, 1991
181. Lin FT, Lane MD: CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 91:8757, 1994
182. Hendricks-Taylor LR, Darlington GJ: Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acids Res 23:4726, 1995
183. Watkins PJ, Condreay JP, Huber BE, Jacobs SJ, Adams DJ: Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Res 56:1063, 1996
184. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ: CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation though the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 10:804, 1996
185. Williams SC, Cantwell CA, Johnson PF: A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev 5:1553, 1991
186. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T: A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9:1897, 1990
187. Chumakov AM, Griller I, Chumakova E, Chih D, Slater J, Koeffler HP: Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor. Mol Cell Biol 17:1375, 1997
188. Antonson P, Stellan B, Yamanaka R, Xanthopoulos KG: A novel human CCAAT/enhancer binding protein gene, C/EBP∈, is expressed in cells of lymphoid and myeloid lineages and is localized on chromsome 14q11.2 close to the T-cell receptor α/δ locus. Genomics 35:30, 1996
189. Descombes P, Schibler U: A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569, 1991
190. Ossipow V, Descombes P, Schibler U: CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA 90:8219, 1993
191. Ron D, Habener JF: CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6:439, 1992
192. Friedman AD: GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells. Cancer Res 56:3250, 1996
193. Christy RJ, Kaestner KH, Geiman DE, Lane MD: CCAAT/enhancer binding protein gene promoter: Binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 88:2593, 1991
194. Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB: c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J 13:4070, 1994
195. Timchenko N, Wilson DR, Taylor LR, Abdelsayed S, Wilde M, Sawadogo M, Darlington GJ: Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol 15:1192, 1995
196. Scott LM, Civin CI, Rorth P, Friedman AD: A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80:1725, 1992
197. Katz S, Kowenzleutz E, Muller C, Meese K, Ness SA, Leutz A: The NF-M transcription factor is related to C/EBP-beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. EMBO J 12:1321, 1993
198. Ness SA, Kowenzleutz E, Casini T, Graf T, Leutz A: Myb and NF-M - Combinatorial activators of myeloid genes in heterologous cell types. Genes Dev 7:749, 1993
199. Sterneck E, Muller C, Katz S, Leutz A: Autocrine growth induced by kinase type oncogenes in myeloid cells requires AP-1 and NF-M, a myeloid specific, C/EBP-like factor. EMBO J 11:115, 1992
200. Haas JG, Strobel M, Leutz A, Wendelgass P, Muller C, Sterneck E, Riethmuller G, Ziegler-Heitbrock HW: Constitutive monocyte-restricted activity of NF-M, a nuclear factor that binds to a C/EBP motif. J Immunol 149:237, 1992
201. Natsuka S, Akira S, Nishio Y, Hashimoto S, Sugita T, Isshiki H, Kishimoto T: Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79:460, 1992
202. Landschulz WH, Johnson PF, McKnight SL: The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 240:1759, 1988
203. Williams SC, Baer M, Dillner AJ, Johnson PF: CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J 14:3170, 1995
204. Friedman AD, McKnight SL: Identification of two polypeptide segments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene. Genes Dev 4:1416, 1990
205. Jones KA, Kadonaga JT, Rosenfeld PJ, Kelly TJ, Tjian R: A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48:79, 1987
206. Dorn A, Bollekens J, Staub A, Benoist C, Mathis D: A multiplicity of CCAAT box-binding proteins. Cell 50:863, 1987
207. van Huijsduijnen RH, Li XY, Black D, Matthes H, Benoist C, Mathis D: Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO J 9:3119, 1990
208. Maity SN, Sinha S, Ruteshouser EC, de Crombrugghe B: Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem 267:16574, 1992
209. Pope RM, Leutz A, Ness SA: C/EBP beta regulation of the tumor necrosis factor alpha gene. J Clin Invest 94:1449, 1994
210. Osada S, Yamamoto H, Nishihara T, Imagawa M: DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem 271:3891, 1996
211. Stein B, Cogswell PC, Baldwin AS Jr: Functional and physical associations between NF-kB and C/EBP family members: A Rel domain-bZIP interaction. Mol Cell Biol 13:3964, 1993
212. Diehl JA, Hannink M: Identification of a C/EBP-Rel complex in avian lymphoid cells. Mol Cell Biol 14:6635, 1994
213. Lee YH, Yano M, Liu SY, Matsunaga E, Johnson PF, Gonzalez FJ: A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an Sp1 factor. Mol Cell Biol 14:1383, 1994
214. Chen PL, Riley DJ, Chen-Kiang S, Lee WH: Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Nati Acad Sci USA 93:465, 1995
215. Hsu W, Kerppola TK, Chen P, Curran T, Chen-Kiang S: Fos and jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol Cell Biol 14:268, 1993
216. Zhang D-E, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW, Jenen DG: CCAAT enhancer binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the M-CSF receptor promoter. Mol Cell Biol 16:1231, 1996
217. Chen PL, Riley DJ, Chen YM, Lee WH: Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Gene Dev 10:2794, 1996
218. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ: Impaired energy homeostasis in C/EBPα knockout mice. Science 269:1108, 1995
219. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos KG: Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein α. J Biol Chem 271:24753, 1996
220. Lui F, Wu HY, Wesselschmidt RL, Kornaga T, Link DC: Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5:491, 1996
221. Metz R, Ziff E: cAMP stimulates the C/EBP-related transcription factor NFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev 5:1754, 1991
222. Wegner M, Cao Z, Rosenfeld MG: Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta. Science 256:370, 1992
223. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T: Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macroophages. Cell 80:353, 1995
224. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, Scarpa S, Bellavia D, Lattanzio G, Bistoni F, Frati L, Cortese R, Gulino A, Ciliberto G, Costantini F, Poli V: Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J 14:1932, 1995
225. Akira S, Yoshida K, Tanaka T, Taga T, Kishimoto T: Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6. Immunol Rev 148:221, 1995
226. Crozat A, Aman P, Mandahl N, Ron D: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640, 1993
227. Hendricks-Taylor LR, Bachinski LL, Siciliano MJ, Fertitta A, Trask B, de Jong PJ, Ledbetter DH, Darlington GJ: The CCAAT/enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) gene maps to human chrosome 20q13.1. Genomics 14:12, 1992
228. Barberis A, Superti-Furga G, Busslinger M: Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter. Cell 50:347, 1987
229. Skalnik DG, Strauss EC, Orkin SH: CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J Biol Chem 266:16736, 1991
230. Neufeld EJ, Skalnik DG, Lievens PM, Orkin SH: Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut. Nat Genet 1:50, 1992
231. Khanna-Gupta A, Zibello T, Neufeld E, Berliner N: CCAAT displacement protein (CDP) recognizes a silencer element within the lactoferrin gene promoter. Blood (submitted)
232. He GP, Mulse A, Li AW, Ro HS: A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature 378:92, 1995
233. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA: Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13:3324, 1993
234. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y: PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila Runt gene and the human AML1 gene. Proc Natl Acad Sci USA 90:6859, 1993
235. Levanon D, Negreanu V, Bernstein Y, Baram I, Avivi L, Groner Y: AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425, 1994
236. Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H: An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J 14:341, 1995
237. Takahashi A, Satake M, Yamaguchiiwai Y, Bae SC, Lu J, Maruyama M, Zhang YW, Oka H, Arai N, Arai K, Ito Y: Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood 86:607, 1995
238. Miyoshi H, Ohira M, Shimizu K, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E, Ohki M: Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res 23:2762, 1995
239. Meyers S, Lenny N, Hiebert SW: The 1(8:21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol 15:1974, 1995
240. Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, Ohki M, Pepling M, Gergen P: The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet 9:338, 1993
241. Kania MA, Bonner AS, Duffy JB, Gergen JP: The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. Genes Dev 4:1701, 1990
242. Meyers S, Downing JR, Hiebert SW: Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins - The Runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 13:6336, 1993
243. Tanaka K, Tanaka T, Ogawa S, Kurokawa M, Mitani K, Yazaki Y, Hirai H: Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells. Biochem Biophys Res Commun 211:1023, 1995
244. Zhu X, Yeadon JE, Burden SJ: AML1 is expressed in skeletal muscle and is regulated by innervation. Mol Cell Biol 14:8051, 1994
245. Wang Q, Stacy T, Miller JD, Lewis AF, Gu T-L, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marin-Padilla M, Sharpe AH, Speck NA: The CBF β subunit is essential for CBFα2 (AML1) function in vivo. Cell 87:697, 1996
246. Zhang D-E, Hohaus S, Voso MT, Chen HM, Smith LT, Hetherington CJ, Tenen DG: Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: Regulation of multiple myeloid CSF receptor promoters. Curr Top Microbiol Immunol 211:137, 1996
247. Giese K, Kingsley C, Kirshner JR, Grosschedl R: Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9:995, 1995
248. Hernandez-Munain C, Krangel MS: Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors. Mol Cell Biol 14:473, 1994
249. Wotton D, Ghysdael J, Wang S, Speck NA, Owen MJ: Cooperative binding of Ets-1 and core binding factor to DNA. Mol Cell Biol 14:840, 1994
250. Sun WW, Graves BJ, Speck NA: Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins. J Virol 69:4941, 1995
251. Tanaka T, Kurokawa M, Ueki K, Tanaka K, Imai Y, Mitani K, Okazaki K, Sagata N, Yazaki Y, Shibata Y, Kadowaki T, Hirai H: The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol Cell Biol 16:3967, 1996
252. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M: The t(8-21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 12:2715, 1993
253. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H: Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80:1825, 1992
254. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H: Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13:504, 1994
255. Nucifora G, Begy CR, Erickson P, Drabkin HA, Rowley JD: The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER-1. Proc Natl Acad Sci USA 90:7784, 1993
256. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA: The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662, 1995
257. Nucifora G, Birn DJ, Espinosa R, Erickson P, LeBeau MM, Roulston D, McKeithan TW, Drabkin H, Rowley JD: Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 81:2728, 1993
258. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS: Fusion between transcription factor CBF-beta/PEBP2-beta and a myosin heavy chain in acute myeloid leukemia. Science 261:1041, 1993
259. Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW, Nimer SD: The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11:2667, 1995
260. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussell MF, Gilliland DG, Lenny N, Meyers S: The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16:1349, 1996
261. Taylor DS, Laubach JP, Nathan DG, Mathey-Prevot B: Cooperation between core binding factor and adjacent promoter elements contributes to the tissue-specific expression of interleukin-3. J Biol Chem 271:14020, 1996
262. Uchida H, Zhang J, Nimer SD: AML1A and AML1B can transactivate the human IL-3 promoter. J Immunol 158:2251, 1997
263. Friedman AD, Britosbray M, Suzow J: The murine myeloperoxidase gene contains a bipartite distal enhancer, including a novel region regulated by PEBP2/CBF. Leuk Res 20:809, 1996
264. Rhoades KL, Hetherington CJ, Rowley JD, Hiebert SW, Nucifora G, Tenen DG, Zhang D-E: Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc Natl Acad Sci USA 93:11895, 1996
265. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701, 1991
266. Borycki AG, Foucrier J, Saffar L, Leibovitch SA: Repression of the CSF-1 receptor (c-fms proto-oncogene product) by antisense transfection induces G1-growth arrest in L6 alpha 1 rat myoblasts. Oncogene 10:1799, 1995
267. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER: The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665, 1985
268. Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ: Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 325:549, 1987
269. Gisselbrecht S, Fichelson S, Sola B, Bordereaux D, Hampe A, Andre C, Galibert F, Tambourin P: Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature 329:259, 1987
270. Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, Zhang D-E: Embryonic lethality and impairment of hemtopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet 15:303, 1997
271. Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marin-Padilla M, Collins FS, Wynshaw-Boris A, Liu PP: Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFβ-MYH11. Cell 87:687, 1996
272. Hodges RE, Sauberlich HE, Canham JE, Wallace DL, Rucker RB, Mejia LA, Mohanram M: Hematopoietic studies in vitamin A deficiency. Am J Clin Nutr 31:876, 1978
273. Douer D, Koeffler HP: Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 138:193, 1982
274. Gratas C, Menot ML, Dresch C, Chomienne C: Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 7:1156, 1993
275. Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936, 1980
276. Breitman TR, Collins SJ, Keene BR: Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 57:1000, 1981
277. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 83:841, 1995
278. Evans RM: The steroid and thyroid hormone receptor super-family. Science 240:889, 1988
279. Glass CK, DiRenzo J, Kurokawa R, Han ZH: Regulation of gene expression by retinoic acid receptors. DNA Cell Biol 10:623, 1991
280. de The H, Marchio A, Tiollais P, Dejean A: Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. EMBO J 8:429, 1989
281. Gallagher RE, Said F, Pua I, Papenhausen PR, Paietta E, Wiernik PH: Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid. Leukemia 3:789, 1989
282. Largman C, Detmer K, Corral JC, Hack FM, Lawrence HJ: Expression of retinoic acid receptor alpha mRNA in human leukemia cells. Blood 74:99, 1989
283. Umesono K, Murakami KK, Thompson CC, Evans RM: Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255, 1991
284. Naar AM, Boutin JM, Lipkin SM, Yu VC, Holloway JM, Glass CK, Rosenfeld MG: The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65:1267, 1991
285. Gudas LJ: Retinoids and vertebrate development. J Biol Chem 269:15399, 1994
286. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM: Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6:329, 1992
287. Collins SJ, Robertson KA, Mueller L: Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol Cell Biol 10:2154, 1990
288. Robertson KA, Emami B, Collins SJ: Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885, 1992
289. Robertson KA, Emami B, Mueller L, Collins SJ: Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Mol Cell Biol 12:3743, 1992
290. Tsai S, Bartelmez S, Heyman R, Damm K, Evans R, Collins SJ: A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 6:2258, 1992
291. Warrell RP Jr, de The H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
292. de The H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347:558, 1990
293. Chang KS, Stass SA, Chu DT, Deaven LL, Trujillo JM, Freireich EJ: Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol Cell Biol 12:800, 1992
294. Goddard AD, Borrow J, Freemont PS, Solomon E: Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254:1371, 1991
295. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66:663, 1991
296. Alcalay M, Zangrilli D, Pandolfi PP, Longo L, Mencarelli A, Giacomucci A, Rocchi M, Biondi A, Rambaldi A, Lo Coco F: Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. Proc Natl Acad Sci USA 88:1977, 1991
297. Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, LoCoco F, Pelicci PG: Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285, 1991
298. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P: PMLRAR homodimers - Distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 12:3171, 1993
299. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
300. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S, Zelent A: Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 12:1161, 1993
301. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ: The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87:882, 1996
302. Guidez F, Huang W, Tong JH, Dubois C, Balitrand N, Waxman S, Michaux JL, Martiat P, Degos L, Chen Z, Waxman S, Chomienne C: Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient. Leukemia 8:312, 1994
303. Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller WH Jr, Zelenetz AD, Willman CL, Chen Z, Chen S-J, Zelent A, Macintyre E, Veil A, Cortes J, Kantarjian H, Waxman S: Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85:1083, 1995
304. Rousselot P, Hardas B, Patel A, Guidez F, Gaken J, Castaigne S, Dejean A, Dethe H, Degos L, Farzaneh F, Chomienne C: The PML-Rar alpha gene product of the t(1517) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene 9:545, 1994
305. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukemia-specific PML-RAR-alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
306. Chomienne C, Balitrand N, Ballerini P, Castaigne S, de The H, Degos L: All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. J Clin Invest 88:2150, 1991
307. Leroy P, Nakshatri H, Chambon P: Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element. Proc Natl Acad Sci USA 88:10138, 1991
308. Liu M, lavarone A, Freedman LP: Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor -Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271:31723, 1996
309. Lawrence HJ, Largman C: Homeobox genes in normal hematopoiesis and leukemia. Blood 80:2445, 1992
310. Lowney P, Corral J, Detmer K, LeBeau MM, Deaven L, Lawrence HJ, Largman C: A human Hox 1 homeobox gene exhibits myeloid-specific expression of alternative transcripts in human hematopoietic cells. Nucleic Acids Res 19:3443, 1991
311. Shen WF, Largman C, Lowney P, Corral JC, Detmer K, Hauser CA, Simonitch TA, Hack FM, Lawrence HJ: Lineage-restricted expression of homeobox-containing genes in human hematopoietic cell lines. Proc Natl Acad Sci USA 86:8536, 1989
312. Magli MC, Barba P, Celetti A, De Vita G, Cillo C, Boncinelli E: Coordinate regulation of HOX genes in human hematopoietic cells. Proc Natl Acad Sci USA 88:6348, 1991
313. Shen WF, Detmer K, Mathews CH, Hack FM, Morgan DA, Largman C, Lawrence HJ: Modulation of homeobox gene expression alters the phenotype of human hematopoietic cell lines. EMBO J 11:983, 1992
314. Lawrence HJ, Sauvageau G, Humphries RK, Largman C: The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem Cells 14:281, 1996
315. Boylan JF, Lufkin T, Achkar CC, Taneja R, Chambon P, Gudas LJ: Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 15:843, 1995
316. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D-3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142, 1996
317. Burn TC, Petrovick MS, Hohaus S, Rollins BJ, Tenen DG: Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines. Blood 84:2776, 1994
318. Kastner P, Mark M, Chambon P: Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell 83:859, 1995
319. Kastner P, Grondona JM, Mark M, Gansmuller A, Lemeur M, Decimo D, Vonesch JL, Dolle P, Chambon P: Genetic analysis of RXR alpha, developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78:987, 1994
320. Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, Gansmuller A, Chambon P: Function of the retinoic acid receptors (RARs) during development (1). Craniofacial and skeletal abnormalities in RAR double mutants. Development 120:2723, 1994
321. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, Lemeur M, Chambon P, Mark M: Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120:2749, 1994
322. Klug A, Rhodes D: Zinc fingers: A novel protein fold for nucleic acid recognition. Cold Spring Harb Symp Quant Biol 52:473, 1987
323. Bogaert T, Brown N, Wilcox M: The Drosophila PS2 antigen is an invertebrate integrin that, like the fibronectin receptor, becomes localized to muscle attachments. Cell 51:929, 1987
324. Sukhatme VP: The Egr transcription factor family: From signal transduction to kidney differentiation. Kidney Int 41:550, 1992
325. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA: Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774, 1990
326. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509, 1990
327. Gabig TG, Mantel PL, Rosli R, Crean CD: Requiem: A novel zinc finger gene essential for apoptosis in myeloid cells. J Biol Chem 269:29515, 1994
328. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN: Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54:831, 1988
329. Sacchi N, Nisson PE, Watkins PC, Faustinella F, Wijsman J, Hagemeijer A: AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts. Gene Chromosome Cancer 11:226, 1994
330. Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H: Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol Cell Biol 15:2383, 1995
331. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ: A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 78:1413, 1991
332. Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R, Zelent A: Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 86:4544, 1995
333. Licht JD, Shaknovich R, English MA, Melnick A, Li JY, Reddy JC, Dong S, Chen SJ, Zelent A, Waxman S: Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. Oncogene 12:323, 1996
334. Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoproteinn. Cell 76:333, 1994
335. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmofonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76:345, 1994
336. Koken MH, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Pavion E, de The H: The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13:1073, 1994
337. Li JY, English MA, Bischt S, Waxman S, Licht JD: DNA binding and transcriptional regulation by the promyelocytic zinc finger protein. Blood 84:41a, 1994 (abstr, suppl 1)
338. Bardwell VJ, Treisman R: The POZ domain: A conserved protein-protein interaction motif. Genes Dev 8:1664, 1994
339. Albagli O, Dhordain P, Deweindt C, Lecocq G, Leprince D: The BTB/POZ domain: A new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ 6:1193, 1995
340. Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ, Wang ZY, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A, Chen SJ: Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc Natl Acad Sci USA 93:3624, 1996
341. Tsai S, Bartelmez S, Sitnicka E, Collins S: Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 8:2831, 1994
342. Corey SJ, Locker J, Oliveri DR, Shekhter-Levin S, Redner RL, Penchansky L, Gollin SM: A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features. Leukemia 8:1350, 1994
343. Shaknovich R, Yeyati PL, Waxman S, Hellinger N, Nason-Burchenal K, Dmitrovsky E, Strutt P, Zelent AD, Licht JD: The promyelocytic leukemia zinc finger protein (PLZF) suppresses growth and induces apoptosis in the 32DCL3 myeloid cell line. Blood 88:555a, 1996 (abstr, suppl 1)
344. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS: PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858, 1994
345. Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J, Juhlin L, Degos L, Calvo F, de The H: The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315, 1995
346. Le XF, Yang P, Chang KS: Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J Biol Chem 271:130, 1996
347. Hromas R, Collins SJ, Hickstein D, Raskind W, Deaven LL, O'Hara P, Hagen FS, Kaushansky K: A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J Biol Chem 266:14183, 1991
348. Bavisotto L, Kaushansky K, Lin N, Hromas R: Antisense oligonucleotides from the stage-specific myeloid zinc finger gene MZF-1 inhibit granulopoiesis in vitro. J Exp Med 174:1097, 1991
349. Hoffman SM, Hromas R, Amemiya C, Mohrenweiser HW: The location of MZF-1 at the telomere of human chromosome 19q makes it vulnerable to degeneration in aging cells. Leuk Res 20:281, 1996
350. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857, 1994
351. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315, 1995
352. Morris JF, Hromas R, Rauscher FJ: Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: Two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core. Mol Cell Biol 14:1786, 1994
353. Morris JF, Rauscher FJ, Davis B, Klemsz M, Xu D, Tenen D, Hromas R: The myeloid zinc finger gene, MZF-1, regulates the CD34 promoter in vitro. Blood 86:3640, 1995
354. Perrotti D, Melotti P, Skorski T, Casella I, Peschle C, Calabretta B: Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: Correlation with negative regulation of CD34 and c-myb promoter activity. Mol Cell Biol 15:6075, 1995
355. Hromas R, Morris J, Cornetta K, Berebitsky D, Davidson A, Sha M, Sledge G, Rauscher F: Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic. Cancer Res 55:3610, 1995
356. Hromas R, Boswell S, Shen RN, Burgess G, Davidson A, Cornetta K, Sutton J, Robertson K: Forced over-expression of the myeloid zinc finger gene MZF-1 inhibits apoptosis and promotes oncogenesis in interleukin-3-dependent FDCP.1 cells. Leukemia 10:1049, 1996
357. Robertson K, Hill D, Ewing C, Srour E, Grigsby S, Hromas R: The myeloid zinc finger gene MZF-1 inhibits retinoic acid-induced apoptosis and CD18 expression in HL60 cells. Blood 86:14a, 1995 (abstr, suppl 1)
358. Hui P: Structural and functional characterization of human myeloid zinc finger gene-1 (MZF-1). Diss Abstr Int 55:2089, 1994
359. Sukhatme VP: The Egr family of nuclear signal transducers. Am J Kidney Dis 17:615, 1991
360. Bedford FK, Ashworth A, Enver T, Wiedemann LM: HEX: A novel homeobox gene expressed during haematopoiesis and conserved between mouse and human. Nucleic Acids Res 21:1245, 1993
361. Lee SL, Wang Y, Milbrandt J: Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transactivation factor NGFI-A (EGR1). Mol Cell Biol 16:4566, 1996
362. Reddy JC, Licht JD: The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochim Biophys Acta 1287:1, 1996
363. Rauscher FJ, Morris JF, Tournay OE, Cook DM, Curran T: Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259, 1990
364. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ: WT1-mediated growth suppression of Wilms' tumor cells expressing a WT1 splicing variant. Science 262:2057, 1993
365. Luo XN, Reddy JC, Yeyati PL, Idris AH, Hosono S, Haber DA, Licht JD, Atweh GF: The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene 11:743, 1995
366. Werner H, Shen-Orr Z, Rauscher FJ, Morris JF, Roberts CT Jr, Leroith D: Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol Cell Biol 15:3516, 1995
367. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, Rosner MR, Haber DA: WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14:4662, 1995
368. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T: WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071, 1994
369. Fraizer GC, Patmasiriwat P, Zhang X, Saunders GF: Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow. Blood 86:4704, 1995
370. Phelan SA, Lindberg C, Call KM: Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ 5:677, 1994
371. Sekiya M, Adachi M, Hinoda Y, Imai K, Yachi A: Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood 83:1876, 1994
372. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 74:679, 1993
373. Miwa H, Beran M, Saunders GF: Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6:405, 1992
374. Hoffman B, Liebermann DA, Selvakumaran M, Nguyen HQ: Role of c-myc in myeloid differentiation, growth arrest and apoptosis. Curr Top Microbiol Immunol 211:17, 1996
375. Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L: The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 8:2138, 1994
376. Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ: A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12:1005, 1996
377. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T: Growth inhibition of human leukemic cells by WT1 (Wilms' tumor gene) antisense oligodeoxynucleotides: Implications for the involvement of WT1 in leukemogenesis. Blood 87:2878, 1996
378. Pritchard-Jones K, Renshaw J, King-Underwood L: The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient. Hum Mol Genet 3:1633, 1994
379. Reddy JC, Morris JC, Wang J, English MA, Haber DA, Shi Y, Licht JD: WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J Biol Chem 270:10878, 1995
380. Englert C, Vidal M, Maheswaran S, Ge Y, Ezzell RM, Isselbacher KJ, Haber DA: Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc Natl Acad Sci USA 92:11960, 1995
381. Moffett P, Bruening W, Nakagama H, Bardeesy N, Housman D, Housman DE, Pelletier J: Antagonism of WT1 activity by protein self-association. Proc Natl Acad Sci USA 92:11105, 1995
382. McCann S, Sullivan J, Guerra J, Arcinas M, Boxer LM: Repression of the c-myb gene by WT1 protein in T and B cell lines. J Biol Chem 270:23785, 1995
383. Hoffman-Liebermann B, Liebermann DA: Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells. Oncogene 6:903, 1991
384. Anfossi G, Gewirtz AM, Calabretta B: An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acad Sci USA 86:3379, 1989
385. McGinnis W, Garber RL, Wirz J, Kuroiwa A, Gehring WJ: A homologous protein-coding sequence in Drosophila homeotic genes and its conservation in other metazoans. Cell 37:403, 1984
386. Scott MP, Weiner AJ: Structural relationships among genes that control development: Sequence homology between the Antennapedia. Ultrabithorax, and fushi tarazu loci of Drosophila. Proc Natl Acad Sci USA 81:4115, 1984
387. Krumlauf R: Hox genes in vertebrate development. Cell 78:191, 1994
388. Zhang P, Benson GV, Rhoades KL, Maas RL, Tenen DG: HoxA-10 deficient mice exhibit increased myelopoiesis and over-proliferation of myeloid colony forming units. Proc Natl Acad Sci USA (submitted)
389. Thorsteinsdottir U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ, Largman C, Humphries RK: Overexpression of HoxA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol 17:495, 1996
390. Satokata I, Benson GV, Maas RL: Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature 374:460, 1995
391. Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon D, Humphries RK, Largman C: Mice bearing targeted interruptions of the homeobox gene hoxa9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89:1922, 1997
392. Perkins AC, Cory S: Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. EMBO J 12:3835, 1993
393. Perkins A, Kongsuwan K, Visvader J, Adams JM, Cory S: Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc Natl Acad Sci USA 87:8398, 1990
394. Deguchi Y, Kirschenbaum A, Kehrl JH: A diverged homeobox gene is involved in the proliferation and lineage commitment of human hematopoietic progenitors and highly expressed in acute myelogenous leukemia. Blood 79:2841, 1992
395. Allen JD, Adams JM: Enforced expression of Hlx homeobox gene prompts myeloid cell maturation and altered adherence properties of T cells. Blood 81:3242, 1993
396. Lill MC, Fuller JF, Herzig R, Crooks GM, Gasson JC: The role of the homeobox gene, HOX B7, in human myelomonocytic differentiation. Blood 85:692, 1995
397. Hromas R, Radich J, Collins S: PCR Cloning of an orphan homeobox gene (PRH) preferentially expressed in myeloid and liver cells. Biochem Biophys Res Commun 195:976, 1993
398. Crompton MR, Bartlett TJ, Macgregor AD, Manfioletti G, Buratti E, Giancotti V, Goodwin GH: Identification of a novel vertebrate homeobox gene expressed in haematopoietic cells. Nucleic Acids Res 20:5661, 1992
399. Manfioletti G, Gattei V, Buratti E, Rustighi A, De Iuliis A, Aldinucci D, Goodwin GH, Pinto A: Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells. Blood 85:1237, 1995
400. Yu BD, Hess JL, Horning SE, Brown GAJ, Korsmeyer SJ: Altered Hox expression and segmental identity in Mil-mutant mice. Nature 378:505, 1995
401. Domer PH, Fakharzadeh SS, Chen CS, Jockel J, Johansen L, Silverman GA, Kersey JH, Korsmeyer SJ: Acute mixed-lineage leukemia t(4;11)(q21;q23) generates a MLL-AF4 fusion product. Proc Natl Acad Sci USA 90:7884, 1993
402. Corral J, Forster A, Thompson S, Lampert F, Kaneko Y, Slater R, Kroes WG, Vanderschoot CE, Ludwig WD, Karpas A, Pocock C, Cotter F, Rabbitts TH: Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA 90:8538, 1993
403. Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, Largman C, Cleary ML: Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev 9:663, 1995
404. Kamps MP, Baltimore D: E2A-Pbx1, the 1(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol 13:351, 1993
405. Luscher B, Eisenman RN: New light on Myc and Myb. Part II. Myb. Genes Dev 4:2235, 1990
406. Golay J, Basilico L, Loffarelli L, Songia S, Broccoli V, Introna M: Regulation of hematopoietic cell proliferation and differentiation by the myb oncogene family of transcription factors. Int J Clin Lab Res 26:24, 1996
407. Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer KH: Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335:835, 1988
408. Melotti P, Ku D-H, Calabretta B: Regulation of the expression of the hematopoietic stem cell antigen CD34: Role of c-myb. J Exp Med 179:1023, 1994
409. Burn TC, Satterthwaite AB, Tenen DG: The human CD34 hematopoietic stem cell antigen promoter and a 3′ enhancer direct hematopoietic expression in tissue culture. Blood 80:3051, 1992
410. Krause DS, Fackler MJ, Civin CI, May WS: CD34: Structure, biology, and clinical utility. Blood 87:1, 1996
411. Shapiro LH: Myb and Ets proteins cooperate to transactivate an early myeloid gene. J Biol Chem 270:8763, 1995
412. Burk O, Mink S, Ringwald M, Klempnauer KH: Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J 12:2027, 1993
413. Oelgeschlager M, Janknecht R, Krieg J, Schreek S, Luscher B: Interaction of the co-activator CBP with Myb proteins: Effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J 15:2771, 1996
414. Cogswell JP, Cogswell PC, Kuehl WM, Cuddihy AM, Bender TM, Engelke U, Marcu KB, Ting JPY: Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol Cell Biol 13:2858, 1993
415. Henriksson M, Luscher B: Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68:109, 1996
416. Luscher B, Eisenman RN: New light on Myc and Myb. Part I. Myc. Genes Dev 4:2025, 1990
417. Selvakumaran M, Liebermann D, Hoffman-Liebermann B: Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis. Blood 81:2257, 1993
418. Ayer DE, Eisenman RN: A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 7:2110, 1993
419. Larsson LG, Pettersson M, Oberg F, Nilsson K, Luscher B: Expression of mad, mxi1, max and c-myc During Induced Differentiation of Hematopoietic Cells - Opposite regulation of mad and c-myc. Oncogene 9:1247, 1994
420. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ: A cooperative interaction between NF-kappa-B and Sp1 is required for HIV-1 enhancer activation. EMBO J 12:3551, 1993
421. Grove M, Plumb M: C/EBP, NF-kappa-B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein-1-alpha immediate-early gene. Mol Cell Biol 13:5276, 1993
422. Stein B, Baldwin AS Jr: Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kB. Mol Cell Biol 13:7191, 1993
423. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA, Bravo R: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 80:331, 1995
424. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691, 1992
425. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, LeBeau MM, Diaz MO, Rowley JD: Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329:909, 1993
426. Zeleznik-Le NJ, Harden AM, Rowley JD: 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc Natl Acad Sci USA 91:10610, 1994
427. Fidanza V, Melotti P, Yano T, Nakamura T, Bradley A, Canaani E, Calabretta B, Croce CM: Double knockout of the ALL-1 gene blocks hematopoietic differentiation in vitro. Cancer Res 56:1179, 1996
428. Mashal R, Shtalrid M, Talpaz M, Kantarjian H, Smith L, Beran M, Cork A, Trujillo J, Gutterman J, Deisseroth A: Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood 75:180, 1990
429. Nakai H, Misawa S, Toguchida J, Yandell DW, Ishizaki K: Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Cancer Res 52:6588, 1992
430. Lanza F, Bi S: Role of p53 in leukemogenesis of chronic myeloid leukemia. Stem Cells 13:445, 1995
431. Zauberman A, Lupo A, Oren M: Identification of p53 target genes through immune selection of genomic DNA: The cyclin G gene contains two distinct p53 binding sites. Oncogene 10:2361, 1995
432. Soddu S, Blandino G, Citro G, Scardigli R, Piaggio G, Ferber A, Calabretta B, Sacchi A: Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood 83:2230, 1994
433. Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tjian R: Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386, 1987
434. Mollinedo F, Gajate C, Tugores A, Flores I, Naranjo JR: Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes. Biochem J 294:137, 1993
435. Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA: Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol 13:841, 1993
436. Salbert G, Fanjul A, Piedrafita FJ, Lu XP, Kim SJ, Tran P, Pfahl M: Retinoic acid receptors and retinoid-X receptor-alpha down-regulate the transforming growth factor-beta(1) promoter by antagonizing AP-1 activity. Mol Endocrinol 7:1347, 1993
437. Doucas V, Brockes JP, Yaniv M, Dethe H, Dejean A: The PML-retinoic acid receptor-alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor-AP-1. Proc Natl Acad Sci USA 90:9345, 1993
438. Satake M, Nomura S, Yamaguchpiiwai Y, Takahama Y, Hashimot Y, Niki M, Kitamura Y, ho Y: Expression of the runt domain-encoding PEBP2 alpha genes in T cells during thymic development. Mol Cell Biol 15:1662, 1995
439. Sposi NM, Zon LI, Care A, Valtieri M, Testa U, Gabbianelli M, Mariani G, Bottero L, Mather C, Orkin SH, Peschle C: Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors. Proc Natl Acad Sci USA 89:6353, 1992
440. Tsai SF, Strauss E, Orkin SH: Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev 5:919, 1991
441. Zon LI, Youssoufian H, Mather C, Lodish HF, Orkin SH: Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci USA 88:10638, 1991
442. Visvader J, Adams IM: Megakaryocytic differentiation in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-aza-cytidine is tightly coupled to GATA-1 expression. Blood 82:1493, 1993
443. Ihle JN: Cytokine receptor signalling. Nature 377:591, 1995
444. Carlesso N, Frank DA, Griffin JD: Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811, 1996
445. Tsui HW, Siminovitch KA, Desouza L, Tsui FWL: Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 4:124, 1993
446. Shultz LD, Schweitzer PA, Rajan TV, Yi TL, Ihle JN, Matthews RI, Thomas ML, Beier DR: Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445, 1993
447. Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, Mccormick F, Jacks T, Shannon K: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 12:144, 1996
448. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nf1 deficiency causes Ras-mediated granulocyte macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat Genet 12:137, 1996
449. Perez C, Coeffier E, Moreau-Gachelin F, Wietzerbin J, Benech PD: Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor. Mol Cell Biol 14:5023, 1994
450. Feinman R, Qiu WQ, Pearse RN, Nikolajczyk BS, Sen R, Sheffery M, Ravetch JV: PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc-gammaRIIIA promoter. EMBO J 13:3852, 1994
451. 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity. Proc Natl Acad Sci USA 92:801, 1995
452. Srikanth S, Rado TA: A 30-base pair element is responsible for the myeloid-specific activity of the human neutrophil elastase promoter. J Biol Chem 269:32626, 1994
453. Carvalho M, Derse D: The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter. J Virol 67:3885, 1993
454. Maury W: Monocyte maturation controls expression of equine infectious anemia virus. J Virol 68:6270, 1994
455. Himmelmann A, Thevenin C, Harrison K, Kehrl JH: Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU1 and SP1 sites. Blood 87:1036, 1996
456. Mitelman F, Heim S: Cancer Cytogentics. New York, NY, Wiley-Liss, 1995, p 69